聖濟堂(600227.SH):2020年度扭虧為盈 預盈5000萬元到7000萬元
格隆匯1月13日丨聖濟堂(600227.SH)發佈2020年年度業績預吿,預計2020年年度實現歸屬於上市公司股東的淨利潤與上年同期相比,將實現扭虧為盈,實現歸屬於上市公司股東的淨利潤5000萬元到7000萬元。歸屬於上市公司股東扣除非經常性損益後的淨利潤3000萬元到5000萬元。
化工業務方面:本次業績預吿期間,公司“煤頭”生產裝置持續穩定運行,尿素、甲醇等主導產品產銷量同比增加;公司原材料煤炭的平均採購價格較去年同期相比有所下降,化工產品原料成本下降;公司“煤頭”生產裝置進行大檢修、技術改造,裝置煤耗同比下降;綜上,公司化工業務實現扭虧為盈。
醫藥業務方面:本次業績預吿期間,由於公司藥品格列美脲片在國家第二批藥品集中帶量採購中中標,使得公司格列美脲片的銷售量同比增加;但是由於多個省市實行價格聯動政策等因素影響,公司藥品平均銷售價格同比下降;同時,公司積極開拓甲巰咪唑腸溶片等新產品的市場,並加大重樓解毒酊等現有產品的銷售推廣力度;綜上,公司醫藥業務淨利潤預計與去年同期基本持平。
本次業績預吿期間,公司確認閒置“氣頭”尿素生產裝置處置收益2929.81萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.